FIELD: biotechnology.
SUBSTANCE: conjugate containing a bacterial capsular saccharide, for example, a capsular saccharide from N. meningitidis serogroup A, C, W135 or Y, covalently bound to a carrier molecule, wherein the carrier molecule contains a single polypeptide chain consisting of one antigen spr0096 and one antigen spr2021.
EFFECT: expansion of the arsenal of technical means in terms of text visualization, enhanced immune response to saccharide compared to the CRM197 carrier protein.
15 cl, 18 dwg, 5 tbl
Authors
Dates
2017-11-22—Published
2012-11-07—Filed